Literature DB >> 11857584

Genetic segregation analysis of recurrent, early-onset major depression: evidence for single major locus transmission.

Brion S Maher1, Mary L Marazita, Wendy N Zubenko, Duane G Spiker, Donna E Giles, Barry B Kaplan, George S Zubenko.   

Abstract

Coordinated efforts are now underway to identify susceptibility genes for unipolar major depressive disorder (MDD) and related disorders. These studies have focused on recurrent, early-onset MDD (RE-MDD), thought to be the most familial form of this disorder. The goal of this study was to conduct a complex segregation analysis of recurrent MDD and other major mood disorders aggregating in families identified by probands with RE-MDD. Eighty-one families were identified through probands over the age of 18 who met criteria for recurrent (> or =2 episodes), early-onset (< or =25 years), nonpsychotic, unipolar MDD (RE-MDD) and included 407 first-degree relatives and 835 extended relatives. Psychiatric diagnoses for probands and their family members who provided blood samples were formulated from structured personal interviews, structured family history assessments, and available medical records. The remaining family members who participated and those who were deceased were evaluated through the family history method augmented by available medical records. Best-estimate diagnoses were made during a consensus conference according to established diagnostic criteria. Segregation analyses were performed using the REGD routine in S.A.G.E. release 4.0. The segregation analysis of recurrent MDD supported a sex-independent Mendelian codominant model. Analysis of major mood disorders supported a sex-independent Mendelian dominant model. Interestingly, inclusion of spousal residual correlations provided better fitting models for recurrent MDD but not the broader phenotype of major mood disorders. Unlike unipolar MDD, the lifetime prevalence of bipolar I disorder in this sample of families did not exceed the reported population prevalence [Zubenko et al., 2001]. Our results suggest that a major locus contributes to the expression of recurrent MDD and possibly other major mood disorders within families identified by probands with RE-MDD. Due to the limitations of the segregation analysis model, our results cannot address whether the same major locus is segregating across families in our sample or whether multiple major loci are involved (genetic heterogeneity). The absence of aggregation of bipolar I disorder in these families strongly suggests that while the genetic determinants of unipolar and bipolar disorders may overlap, they are not identical. Our findings illustrate the advantage of employing families identified by probands with RE-MDD in studies designed to detect susceptibility loci for unipolar MDD and related disorders. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11857584     DOI: 10.1002/ajmg.10158

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  Replacement of homologous mouse DNA sequence with pathogenic 6-base human CREB1 promoter sequence creates murine model of major depressive disorder.

Authors:  George S Zubenko; Hugh B Hughes
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-05-19       Impact factor: 3.568

2.  Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease.

Authors:  Vicki Shanker; Mark Groves; Gary Heiman; Christina Palmese; Rachel Saunders-Pullman; Laurie Ozelius; Deborah Raymond; Susan Bressman
Journal:  Mov Disord       Date:  2011-05-24       Impact factor: 10.338

3.  Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.

Authors:  Andrew A Nierenberg; Madhukar H Trivedi; Maurizio Fava; Melanie M Biggs; Kathy Shores-Wilson; Stephen R Wisniewski; G K Balasubramani; A John Rush
Journal:  J Psychiatr Res       Date:  2006-05-11       Impact factor: 4.791

4.  Effects of the A(-115)G variant on CREB1 promoter activity in two brain cell lines: Interactions with gonadal steroids.

Authors:  George S Zubenko; Hugh B Hughes
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-10-18       Impact factor: 3.568

5.  Familiality of major depressive disorder and patterns of lifetime comorbidity. The NEMESIS and GenMood studies. A comparison of three samples.

Authors:  Maaike Verhagen; Annemarie van der Meij; Barbara Franke; Wilma A M Vollebergh; Ron de Graaf; Jan K Buitelaar; Joost G E Janzing
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-24       Impact factor: 5.270

6.  Effects of the G(-656)A variant on CREB1 promoter activity in a neuronal cell line: interactions with gonadal steroids and stress.

Authors:  G S Zubenko; H B Hughes
Journal:  Mol Psychiatry       Date:  2008-03-04       Impact factor: 15.992

7.  Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q.

Authors:  Peter Holmans; George S Zubenko; Raymond R Crowe; J Raymond DePaulo; William A Scheftner; Myrna M Weissman; Wendy N Zubenko; Sandra Boutelle; Kathleen Murphy-Eberenz; Dean MacKinnon; Melvin G McInnis; Diana H Marta; Philip Adams; James A Knowles; Madeleine Gladis; Jo Thomas; Jennifer Chellis; Erin Miller; Douglas F Levinson
Journal:  Am J Hum Genet       Date:  2004-04-22       Impact factor: 11.025

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.